Last deal
Amount
Stage
Date
all rounds
Total amount
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
Last funding type
IPO status
Contacts
Similar Companies1000
Virtue Health Group
Virtue Health Group is a healthcare organization that provides hospital-level care at home, redefining health system capacity and outcomes.
Sector
Subsector
Keywords
Location
total rounds
total raised
LHC Group
LHC Group delivers in-home health and hospice care to patients with injuries, illnesses, or chronic conditions.
Sector
Subsector
Keywords
Location
Cera
Cera Care is a London-based technology-enabled home care company.
Sector
Subsector
Location
total rounds
total raised
Tembo Health
Tobro Health connects retirement homes, senior care centers and skilled nursing facilities with telemedicine services.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds2
Number of Funding Rounds
Money Raised
Their latest funding was raised on 20.09.2023. Their latest investor Flare Capital Partners. Their latest round Series B
HealthQuest Capital
HealthQuest Capital is a private equity firm that invests in healthcare companies to optimize value, improve outcomes, and lower costs.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Allina Health
Allina Health is a non-profit healthcare system dedicated to the prevention and treatment of illness.
Sector
Subsector
Keywords
Location
count Of Investments
Flare Capital Partners
Flare Capital Partners is a venture capital firm focused on healthcare technology.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors4
Number of lead investors
Number of investors
Flare Capital Partners
Flare Capital Partners is a venture capital firm focused on healthcare technology.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Michael Greeley
Michael Greeley was previously a General Partner at Flybridge Capital Partners whose principle investment focus area is the application of "Big Data" platforms across a number of industry verticals. Michael is most excited about the convergence of healthcare and information technologies and the profound opportunities to transform healthcare. Michael is on the Board of Iora Health and Predilytics, and represented his previous firm on the boards of BlueTarp Financial, MicroCHIPs, PolyRemedy, Predictive Biosciences, SpringLeaf Therapeutics, T2 Biosystems, TARIS Biomedical, and VidSys and led the firm’s investment in lighterliving, Magen BioSciences and Protein Forest. Michael's blog, On the Flying Bridge, can be found at www.ontheflyingbridge.com. You can follow him on Twitter at www.twitter.com/greels1. Michael founded IDG Ventures Atlantic in 2001 before it transitioned to Flybridge Capital Partners in 2008. Michael served on the board of International Data Group, the flagship Limited Partner for the IDG Ventures global network of funds. Previously, Michael was with Polaris Venture Partners, where he focused on both early-stage and later-stage financings for emerging growth companies. Before Polaris, Michael served as Senior Vice President and Founding Partner of GCC Investments, a $200 million private equity fund. Prior to GCC Investments, Michael was a Vice President and one of the early professionals at Wasserstein Perella & Co., an international merchant bank with a $1.0 billion private equity fund. Additionally, Michael was a member of the Mergers and Acquisitions Department of Morgan Stanley & Co. and worked in the Leveraged Buyout Group of Credit Suisse First Boston. In prior positions, Michael has served on the Boards of a number of public and private companies including FleetCor Technologies (NYSE: FLT), Global TeleSystems Group (NASDAQ: GTSG), El Sitio International (NASDAQ: LCTO), MotherNature.com (NASDAQ: MTHR), Crescent Communications (acquired by Clear Channel), and American Capital Access. Michael received a BA with honors in Chemistry from Williams College and an MBA from Harvard Business School.
current job
HealthQuest Capital
HealthQuest Capital is a private equity firm that invests in healthcare companies to optimize value, improve outcomes, and lower costs.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Garheng Kong
Garheng joined Sofinnova Ventures in 2010 as a General Partner to focus on life science investments. He has served as chairman and director on the boards of numerous companies, and operated as interim CEO for two venture-backed companies. For the previous 10 years, he was at Intersouth Partners, most recently as a general partner. During this time he served as the founding investor and chairman of Cellective Therapeutics (acquired by AstraZeneca), Chairman of Serenex (acquired by Pfizer), Chairman of Novamin Technologies (acquired by GlaxoSmithKline), and lead investor of the first financing for Alimera Sciences (Nasdaq: ALIM). He has also led or been significantly involved in the investments of Cempra Pharmaceuticals (Nasdaq: CEMP, Chairman), Viamet Pharmaceuticals (Chairman), Proteon Therapeutics, Applied Genetic Technology Corporation, TransEnterix, Calibra Medical (Acquired by J&J), CancerGuide Diagnostics, Aldagen (Acquired by Cytomedix) and nContact Surgical. Garheng most recently led Sofinnova\'s investment in Alimera Sciences, Histogenics (Chairman), Salveo Specialty Pharmacy and SARcode Bioscience (acquired by Shire). Garheng serves or has served on the boards of directors of the SEBIO organization, the North Carolina Biotechnology Center, the Duke University Medical Center Board of Visitors, the Council for Entrepreneurial Development (CED), the Hamner Institutes for Life Sciences, the North Carolina Medical Device Organization, the University of Florida Biotechnology Council, the University of Virginia Ivy Foundation, the Pennsylvania Life Sciences Greenhouse, the Southeast Universities Research Association, the Investor Advisory Board for the Florida Institute for the Commercialization of Public Research, and the Corporate Chaplains of America. He has also served on the Duke Medical Center Institutional Review Board (IRB) and as faculty at the Duke Fuqua School of Business as a Senior Scholar.
current job
McKesson Ventures
McKesson Ventures is a healthcare-focused venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Activity
Recent News4
The graph reveals the ratio (%) of positive news articles in a chosen time range